Laboratorios Farmaceuticos Rovi (ES:ROVI) has released an update.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Laboratorios Farmacéuticos Rovi, S.A. has announced a modification to the securities and cash balances of its Liquidity Contract with Bestinver SV, S.A. Following the adjustment, the securities account will contain 6,000 shares, and the cash balance will stand at 570,000 euros.
For further insights into ES:ROVI stock, check out TipRanks’ Stock Analysis page.